Hydralazine Hydrochloride
- Product NDC
- 39822-0500
- 11-digit product format
- 398220500
- Labeler code
- 39822
- Product ID
- 39822-0500_eedc429c-f1bd-6111-e053-2995a90a70b4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydralazine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Application
- ANDA203110
- Marketing category
- ANDA
- Marketing start
- 2015-06-29
- Marketing end
- 0000-00-00
- Substance
- HYDRALAZINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 39822-0500-4 | 39822050004 | 25 VIAL in 1 CARTON (39822-0500-4) > 1 mL in 1 VIAL (39822-0500-1) | 25 vial | 2015-06-29 | 0000-00-00 | No | No | Current |